The American Academy of Pediatrics (AAP) has issued its recommendations for the upcoming influenza season, including guidance on administering the vaccine to patients with COVID-19.
As we enter the final weeks of summer, the upcoming flu season looms. With many people back to work and in-person school, it means that season may be more typical than what occurred last season. With this in mind, the American Academy of Pediatrics has issued recommendations for the approaching influenza season.1
A flu shot is recommended for all children aged months and older. Any licensed, age-appropriate inactivated influenza vaccine can be administered to infants and toddlers aged 6 to 35 months. For children aged 3 years and older, any available, licensed vaccine should be given in a 0.5 mL dose. Children with an unknown vaccine status, who have only 1 dose of the vaccine by July 1, 2021, or who are aged 6 months to 8 years and are receiving the vaccine for the first time should be given 2 doses of influenza 4 weeks apart, preferably by the end of October. Ideally, children who require just 1 dose of vaccine should receive it by the end of October as well. Egg allergies should not prevent children from receiving the vaccines. Both inactivated influenza vaccine and live attenuated influenza vaccine can both be administered to them.
The recommendations also carried some updates:
1. Committee on infectious diseases. Recommendations for prevention and control of influenza in children, 2021–2022. Pediatrics. September 7, 2021. Epub ahead of print. doi:10.1542/peds.2021-053744